Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - INTEREST INCOME & EXPENSE
Interest Income & Expense ADAP - Adaptimmune Therapeutics plc
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR